Taylor & Francis
+5
1744-8360
Monthly
3.4
1473-7175
2001
4402080520500
YES
United Kingdom
English
YES
GOOGLE SCHOLAR
enquiries@taylorandfrancis.com
Expert Review of Neurotherapeutics [ISSN 1473-7175]; [e-ISSN 1744-8360] is a MEDLINE-indexed, international subscription-based journal publishing rigorously peer-reviewed review articles and original papers on the use of drugs and medicines in clinical neurology and neuropsychiatry. Articles focus on the following key areas: Disease management New medicines and drugs in neurology Therapeutic indications, diagnostics, medical treatment guidelines Neurological diseases such as stroke, epilepsy, Alzheimer's and Parkinson's Please note that the journal does not publish case reports or case series.
OJSCloud offers a complete, free setup to get you publishing.
Start Your Free Journal!Scholar9.com is a peer-review platform that hosts journals from across the globe. Please note that we do not own any of the journals hosted on the platform.
Our platform enables journal owners to send articles for peer review to users who have registered via https://scholar9.com/register and have consented to serve as reviewers for multiple journals. Additionally, we offer an indirect manuscript submission system for journals that are claimed and actively managed by their respective owners on Scholar9.com.
For accurate information about the indexing status of journals (in databases such as UGC CARE, Scopus, or Web of Science) and contact details, users must refer to the respective official websites.
Scholar9 is not responsible for indexing claims, manuscript acceptance/rejection, refunds of article processing charges, or any stage of the final publication process. Users are strongly advised to verify all information provided on the platform independently.
Scholar9.com disclaims liability for disputes related to indexing claims, publication decisions, or other journal-specific matters. Users are encouraged to contact the respective journal owners directly for detailed information and clarifications.